DEA Publishes Proposal to Reschedule Hydrocodone
Feb 24 (WASHINGTON)
Today the U. S. Drug Enforcement Administration (DEA) published in the Federal Register a Notice of Proposed Rulemaking (NPRM) to move hydrocodone combination products (HCPs) from Schedule III to Schedule II, as recommended by the Assistant Secretary for Health of the U.S. Department of Health and Human Services (HHS) and as supported by the DEA’s own evaluation of relevant data. This NPRM proposes to impose the regulatory controls and sanctions applicable to Schedule II substances on those who handle or propose to handle HCPs. The public is invited to review the proposed rule, which is posted on the DEA’s website.
|MAR 11||(FRESNO, Calif.) Man Pleads Guilty to Trafficking Oxycodone|
|MAR 10||(FRESNO, Calif.) Squaw Valley Marijuana Cultivation Operation|
|MAR 06||(TALLAHASSEE, Fla.) Physician Indicted for Unlawfully Dispensing Controlled Substances|
|MAR 06||(ORLANDO, Fla.) Police Officer Indicted for Participating in a Drug Deal|
|MAR 05||(GULFPORT, Miss.) Indictment Exposes Gulf Coast Prescription Drug Ring|